Pres, Innovation, Tech Aubrey Rankin sold $247K of Revance Therapeutics, Inc.

Sold$246,659

$26.34Price

9,364Shares

−2%Stake

What RVNC did after the filing

Prices for RVNC after this filing aren't in yet.

Traded Mon, Aug 16. Filed Tue, Aug 17, 2:20 PM ET, during the session. Not investment advice.